Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05064826 · ClinicalTrials.gov registry record · NA
ED Observation for Opioid Use Disorder
A NA study of Opioid Use Disorder, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 170
- Enrollment target
- 6
- Study locations
NCT05064826 is a NA study of Opioid Use Disorder that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 170 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (96% lower). The trial reports 6 study locations across 2 states.
The verdict
NCT05064826, a NA study of Opioid Use Disorder, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a multicenter, randomized clinical comparative effectiveness trial (RCT) in which patients with untreated OUD presenting to a Northwell Health Emergency Department (ED), NYULH-Brooklyn, NYULH-Tisch, and Bellevue Hospital will be randomized (1:1) to be managed clinically through either a standard ED visit or an extended visit through ED observation (EDOU).
Conditions Studied
Interventions
- OTHER Observation
Study Locations (6)
New York
- NYULH-Brooklyn - Brooklyn
- Northwell Health - Long Island Jewish Medical Center - New Hyde Park
- Bellevue - New York
- NYULH-Tisch - New York
- Northwell Health - Staten Island University Hospital - Staten Island
New Jersey
- Rutgers University-University Hospital - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2022-04-21 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05064826
The ClinicalTrials.gov registry entry for NCT05064826 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (96% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Observation is the first listed.
NCT05064826 reports 6 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05064826 about?
NCT05064826 is a clinical study titled "ED Observation for Opioid Use Disorder". This is a multicenter, randomized clinical comparative effectiveness trial (RCT) in which patients with untreated OUD presenting to a Northwell Health Emergency Department (ED), NYULH-Brooklyn, NYULH-Tisch, and Bellevue Hospital will be randomized (1:1) to be managed clinically through either a stan...
What is the current status of trial NCT05064826?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 170 participants. The study started on 2022-04-21. Estimated completion is 2026-07-31.
What conditions does trial NCT05064826 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT05064826?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT05064826?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05064826 being conducted?
This trial has 6 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.